APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans
New England Journal of Medicine · 16.01.2025 · 392 (3) · 228-238
DOI: 10.1056/nejmoa2404211 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 16.01.2025. Verfasst von Rasheed A Gbadegesin und 49 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Pediatrics, Duke University Medical Center, Durham (R.A.G.), and the Departments of Medicine (B.I.F.) and Biochemistry (N.D.P.…. Hauptthemen laut MEDLINE: Apolipoprotein L1, Renal Insufficiency, Chronic, Glomerulosclerosis, Focal Segmental. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIDDK NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Apolipoprotein L1 gene (APOL1) variants are risk factors for chronic kidney disease (CKD) among Black Americans. Data are sparse on the genetic epidemiology of CKD and the clinical association of APOL1 variants with CKD in West Africans, a major group in the Black population. METHODS: We conducted a case-control study involving participants from Ghana and Nigeria who had CKD stages 2 through 5, biopsy-proven glomerular disease, or no kidney disease. We analyzed the association of CKD with APOL1 variants among participants with high-risk genotypes (two APOL1 risk alleles) and those with low-risk genotypes (fewer than two APOL1 risk alleles) by fitting logistic-regression models that controlled for covariates, including clinical site, age, and sex. RESULTS: Among 8355 participants (4712 with CKD stages 2 through 5, 866 with glomerular diseases, and 2777 with no kidney disease), the prevalence of monoallelic APOL1 variants was 43.0% and that of biallelic APOL1 variants was 29.7%. Participants with two APOL1 risk alleles had higher odds of having CKD than those with one risk allele or no risk alleles (adjusted odds ratio, 1.25; 95% confidence interval [CI], 1.11 to 1.40), as well as higher odds of focal segmental glomerulosclerosis (adjusted odds ratio, 1.84; 95% CI, 1.30 to 2.61). Participants with one APOL1 risk allele had higher odds of having CKD than those with no risk alleles (adjusted odds ratio, 1.18; 95% CI, 1.04 to 1.33), as well as higher odds of focal segmental glomerulosclerosis (adjusted odds ratio, 1.61; 95% CI, 1.04 to 2.48). The inclusion of covariates did not modify the association of monoallelic and biallelic APOL1 variants with CKD or focal segmental glomerulosclerosis. CONCLUSIONS: In this study, monoallelic APOL1 variants were associated with 18% higher odds of CKD and 61% higher odds of focal segmental glomerulosclerosis; biallelic APOL1 variants were associated with 25% higher odds of CKD and 84% higher odds of focal segmental glomerulosclerosis. (Funded by the National Human Genome Research Institute and others.).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Pediatrics, Duke University Medical Center, Durham (R.A.G.), and the Departments of Medicine (B.I.F.) and Biochemistry (N.D.P.), Wake Forest University School of Medicine, Winston-Salem - both in…
ORCID-Profile: Winfred Williams, Akinlolu Ojo
Förderung
- Intramural NIH HHS
- NIDDK NIH HHS
- NHGRI NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Human Genome Research Institute
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gbadegesin, R. A., Ulasi, I., Ajayi, S., Raji, Y., Olanrewaju, T., Osafo, C., Ademola, A. D., Asinobi, A., Winkler, C. A., Burke, D., Arogundade, F., Ekem, I., Plange-Rhule, J., Mamven, M., Matekole, M., Amodu, O., Cooper, R., Antwi, S., Adeyemo, A. A., …, & H3Africa Kidney Disease Research Network (2025). APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans. New England Journal of Medicine, 392(3), 228-238. https://doi.org/10.1056/nejmoa2404211
Vancouver
Gbadegesin RA, Ulasi I, Ajayi S, Raji Y, Olanrewaju T, Osafo C, et al. APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans. New England Journal of Medicine. 2025;392(3):228-238. doi:10.1056/nejmoa2404211
BibTeX
@article{Gbadegesin2025,
author = {Gbadegesin, Rasheed A and Ulasi, Ifeoma and Ajayi, Samuel and Raji, Yemi and Olanrewaju, Timothy and Osafo, Charlotte and Ademola, Adebowale D and Asinobi, Adanze and Winkler, Cheryl A and Burke, David and Arogundade, Fatiu and Ekem, Ivy and Plange-Rhule, Jacob and Mamven, Manmak and Matekole, Michael and Amodu, Olukemi and Cooper, Richard and Antwi, Sampson and Adeyemo, Adebowale A and Ilori, Titilayo O and Adabayeri, Victoria and Nyarko, Alexander and Ghansah, Anita and Amira, Toyin and Solarin, Adaobi and Awobusuyi, Olugbenga and Kimmel, Paul L and Brosius, Frank Chip and Makusidi, Muhammad and Odenigbo, Uzoma and Kretzler, Matthias and Hodgin, Jeffrey B and Pollak, Martin R and Boima, Vincent and Freedman, Barry I and Palmer, Nicholette D and Collins, Bernard and Phadnis, Milind and Smith, Jill and Agwai, Celia I and Okoye, Ogochukwu and Abdu, Aliyu and Wilson, Jillian and Williams, Winfred and Salako, Babatunde L and Parekh, Rulan S and Tayo, Bamidele and Adu, Dwomoa and Ojo, Akinlolu and H3Africa Kidney Disease Research Network, H3Africa Kidney Disease Research Network},
title = {APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {3},
pages = {228--238},
doi = {10.1056/nejmoa2404211}
}
EUVIMED